European Survey of Cardiovascular Disease Prevention, Diabetes and Chronic Kidney Disease (EUROASPIRE VI)

Launched by EUROPEAN SOCIETY OF CARDIOLOGY · Jul 2, 2024

Keywords

ClinConnect Summary

The EUROASPIRE VI study is looking into how well doctors in Europe are following guidelines for preventing heart disease and managing related conditions like diabetes and kidney disease. This study focuses on patients who have had heart issues, such as heart attacks or unstable angina, as well as those at high risk for heart problems, including individuals with high blood pressure, high cholesterol, and diabetes. The goal is to gather information on the care these patients receive and see if it aligns with the recommended practices for preventing cardiovascular disease.

To participate in the study, individuals must be at least 18 years old and have had a heart-related event or be at high risk for heart disease. Participants will need to provide their consent and should have been in the care of a participating doctor for at least six months but no more than 24 months after their initial event. The study is currently recruiting patients of all genders who meet these criteria. If you join, you can expect to share information about your health and treatment with researchers who are dedicated to improving heart health across Europe.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients having signed an informed Consent
• • Patients aged from 18 years old at the time of identification
• • At least six and at most 24 months elapsed between the index event (the recruiting diagnostic or treatment criteria below) and the date of interview
• * Patients meeting the recruiting diagnostic or treatment criteria:
• • Coronary patients: Acute coronary events (acute coronary syndrome {STEMI or NSTEMI}, unstable angina) or an emergency or elective revascularisation for coronary artery disease (CABG, PCI)
• • High cardiovascular disease (CVD) risk patients: patients free of CVD, who have been prescribed one or more of the following treatments: blood pressure and/or lipid-lowering and/or glucose lowering (diet and/or hypoglycaemic agents and/or insulin)
• Exclusion Criteria:
• • Patients living outside defined geographical areas
• • Patients admitted to hospital from outside the geographical area or under the care of cardiologists in hospitals that do not participate in EUROASPIRE VI